Cancer Incidence and Mortality among Blacks, Monroe County, 2015-2019
Source: New York State Cancer Registry
Site of Cancer | Incidence | Mortality | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 574.0 | 533.1 | 513.1-553.6 | 289.6 | 632.8 | 598.8-668.1 | 284.4 | 463.2 | 438.9-488.5 | 185.6 | 184.3 | 172.2-197.0 | 93.6 | 229.2 | 207.6-252.4 | 92.0 | 155.1 | 140.9-170.3 |
Oral cavity and pharynx | 10.4 | 9.0 | 6.7-11.9 | 7.0 | 14.0 | 9.5-19.8 | 3.4 | 5.3 | 3.1-8.5 | 2.4 | 2.3 | 1.2-4.1 | 1.8 | 4.1 | 1.8-8.0 | 0.6 | 1.0 | 0.2-3.0 |
Esophagus | 4.0 | 4.0 | 2.4-6.1 | 2.8 | 6.8 | 3.6-11.5 | 1.2 | 2.0 | 0.7-4.3 | 3.6 | 3.8 | 2.2-6.0 | 2.0 | 5.5 | 2.5-10.1 | 1.6 | 2.8 | 1.1-5.5 |
Stomach | 12.6 | 13.0 | 9.9-16.8 | 6.8 | 15.5 | 10.5-22.0 | 5.8 | 11.0 | 7.3-15.8 | 5.2 | 4.7 | 3.0-7.0 | 4.6 | 9.3 | 5.7-14.2 | 0.6 | 1.2 | 0.3-3.4 |
Colorectal | 50.4 | 46.2 | 40.5-52.5 | 25.4 | 54.7 | 45.3-65.6 | 25.0 | 40.0 | 33.1-47.8 | 15.2 | 14.6 | 11.4-18.4 | 8.8 | 19.5 | 14.0-26.5 | 6.4 | 11.0 | 7.5-15.6 |
Colon excluding rectum | 36.2 | 33.4 | 28.6-38.8 | 17.8 | 38.0 | 30.2-47.1 | 18.4 | 29.9 | 24.0-36.8 | 12.2 | 11.9 | 9.0-15.3 | 7.0 | 15.7 | 10.7-22.0 | 5.2 | 9.1 | 5.9-13.3 |
Rectum & rectosigmoid | 14.2 | 12.8 | 9.9-16.3 | 7.6 | 16.7 | 11.6-23.2 | 6.6 | 10.0 | 6.9-14.2 | 3.0 | 2.8 | 1.5-4.6 | 1.8 | 3.9 | 1.7-7.5 | 1.2 | 2.0 | 0.7-4.3 |
Liver / intrahepatic bile duct | 14.0 | 11.7 | 9.0-14.9 | 10.2 | 19.3 | 14.2-25.7 | 3.8 | 5.8 | 3.5-9.2 | 10.2 | 9.2 | 6.8-12.2 | 7.4 | 15.8 | 10.9-22.1 | 2.8 | 4.4 | 2.4-7.5 |
Pancreas | 21.4 | 21.6 | 17.6-26.3 | 9.6 | 21.3 | 15.4-28.7 | 11.8 | 21.4 | 16.2-27.7 | 16.6 | 16.6 | 13.1-20.7 | 7.4 | 16.7 | 11.5-23.4 | 9.2 | 16.3 | 11.8-21.8 |
Larynx | 5.0 | 4.5 | 2.9-6.7 | 4.6 | 10.2 | 6.2-15.5 | 0.4 | 0.5 | 0.1-2.0 | 1.8 | 1.6 | 0.7-3.1 | 1.4 | 3.0 | 1.2-6.2 | 0.4 | 0.6 | 0.1-2.3 |
Lung and bronchus | 79.4 | 74.5 | 67.1-82.5 | 41.6 | 96.4 | 83.0-111.3 | 37.8 | 59.9 | 51.5-69.3 | 46.0 | 44.8 | 39.0-51.2 | 25.0 | 61.5 | 50.6-73.9 | 21.0 | 33.8 | 27.5-41.1 |
Melanoma of the skin | 1.2 | 1.2 | 0.4-2.7 | 0.6 | 1.5 | 0.3-4.3 | 0.6 | 1.1 | 0.2-3.1 | 0.4 | 0.4 | 0.0-1.5 | 0.2 | 0.6 | 0.0-3.0 | 0.2 | 0.3 | 0.0-1.7 |
Female breast | 87.4 | 141.8 | 128.5-156.0 | 14.2 | 24.4 | 18.9-30.8 | ||||||||||||
Cervix uteri | 5.2 | 8.2 | 5.3-12.1 | 2.6 | 4.2 | 2.2-7.3 | ||||||||||||
Corpus uterus and NOS | 19.2 | 29.4 | 23.7-36.0 | 6.2 | 9.3 | 6.3-13.3 | ||||||||||||
Ovary | 4.8 | 8.1 | 5.1-12.1 | 3.4 | 6.2 | 3.5-9.9 | ||||||||||||
Prostate | 97.6 | 205.0 | 186.4-225.0 | 10.6 | 33.3 | 24.5-43.8 | ||||||||||||
Testis | 0.6 | 1.1 | 0.2-3.5 | 0.0 | 0.0 | 0.0-1.6 | ||||||||||||
Urinary bladder (incl. in situ) | 13.4 | 13.6 | 10.4-17.4 | 8.6 | 20.9 | 14.8-28.6 | 4.8 | 8.5 | 5.4-12.7 | 1.6 | 1.6 | 0.7-3.2 | 0.8 | 2.1 | 0.5-5.2 | 0.8 | 1.3 | 0.3-3.4 |
Kidney and renal pelvis | 33.0 | 29.8 | 25.3-34.8 | 20.6 | 40.9 | 33.1-49.9 | 12.4 | 20.9 | 15.9-26.9 | 2.6 | 2.6 | 1.3-4.4 | 2.0 | 4.7 | 2.2-8.6 | 0.6 | 1.1 | 0.2-3.0 |
Brain and other central nervous system | 4.2 | 3.7 | 2.3-5.8 | 2.4 | 5.1 | 2.5-9.2 | 1.8 | 2.8 | 1.3-5.3 | 2.0 | 1.9 | 0.9-3.5 | 1.6 | 3.8 | 1.5-7.7 | 0.4 | 0.6 | 0.1-2.1 |
Thyroid | 14.0 | 12.5 | 9.7-15.9 | 3.2 | 8.2 | 4.5-13.4 | 10.8 | 16.3 | 12.2-21.4 | 1.0 | 1.1 | 0.3-2.5 | 0.6 | 2.0 | 0.4-5.5 | 0.4 | 0.6 | 0.1-2.1 |
Hodgkin lymphoma | 4.2 | 3.6 | 2.2-5.5 | 2.2 | 4.1 | 2.0-7.5 | 2.0 | 3.1 | 1.5-5.8 | 0.0 | 0.0 | 0.0-0.7 | 0.0 | 0.0 | 0.0-1.6 | 0.0 | 0.0 | 0.0-1.2 |
Non-Hodgkin lymphomas | 18.0 | 17.5 | 14.0-21.7 | 10.4 | 24.3 | 17.8-32.4 | 7.6 | 12.9 | 9.1-17.9 | 4.0 | 4.2 | 2.5-6.6 | 2.2 | 6.1 | 2.9-11.1 | 1.8 | 3.1 | 1.4-6.0 |
Myeloma | 15.4 | 14.9 | 11.7-18.8 | 7.8 | 18.4 | 12.8-25.4 | 7.6 | 12.6 | 8.9-17.4 | 4.6 | 4.9 | 3.0-7.3 | 2.8 | 7.2 | 3.8-12.2 | 1.8 | 3.2 | 1.4-6.2 |
Leukemias | 10.2 | 10.6 | 7.8-14.0 | 5.8 | 13.5 | 8.8-19.8 | 4.4 | 8.2 | 5.1-12.5 | 6.8 | 7.0 | 4.7-9.8 | 3.4 | 8.0 | 4.5-13.1 | 3.4 | 6.2 | 3.5-9.9 |
Notes
- Incidence data are provisional, November 2021.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.